MedPath

ASAN FOUNDATION

ASAN FOUNDATION logo
πŸ‡°πŸ‡·South Korea
Ownership
Private
Established
1989-06-23
Employees
501
Market Cap
-
Website
https://ails.amc.seoul.kr

Internal Carotid Artery Blood Flow in Robot-Assisted Laparoscopic Prostatectomy

Completed
Conditions
Prostate Cancer
First Posted Date
2020-11-04
Last Posted Date
2021-01-26
Lead Sponsor
Asan Medical Center
Target Recruit Count
28
Registration Number
NCT04615494
Locations
πŸ‡°πŸ‡·

Asan medical Center, Seoul, Korea, Republic of

A Multicenter Prospective Phase II Study of Modified FOLFIRINOX for 1st Line Treatment for Advanced Urachus Cancer

Phase 2
Recruiting
Conditions
Urachal Cancer
Interventions
Drug: FOLFIRINOX
First Posted Date
2020-11-02
Last Posted Date
2020-11-02
Lead Sponsor
Asan Medical Center
Target Recruit Count
35
Registration Number
NCT04611724
Locations
πŸ‡°πŸ‡·

Asan Medical Center, Seoul, Korea, Republic of

Safety of Human Embryonic Stem Cell (hESC)-Derived Mesenchymal Stem Cells in Interstitial Cystitis

Phase 1
Conditions
Stem Cell Transplant
Mesenchymal Stem Cell
Interstitial Cystitis
Interventions
Drug: MR-MC-01
First Posted Date
2020-10-30
Last Posted Date
2020-10-30
Lead Sponsor
Asan Medical Center
Target Recruit Count
3
Registration Number
NCT04610359
Locations
πŸ‡°πŸ‡·

Department of Urology, Asan Medical Center, Seoul, Korea, Republic of

Music and Surgery Associated With Relationship and Satisfaction

Not Applicable
Conditions
Breast Cancer
Interventions
Procedure: Music therapy
First Posted Date
2020-09-18
Last Posted Date
2020-10-06
Lead Sponsor
Asan Medical Center
Target Recruit Count
304
Registration Number
NCT04555057
Locations
πŸ‡°πŸ‡·

Asan Medical Center, Seoul, Korea, Republic of

Randomized, Open-label Trial of Inhibitory Effect of Evogliptin on Progression of CAVD

Phase 4
Not yet recruiting
Conditions
CAVD
Interventions
First Posted Date
2020-08-20
Last Posted Date
2020-08-20
Lead Sponsor
Asan Medical Center
Target Recruit Count
218
Registration Number
NCT04521452
Locations
πŸ‡°πŸ‡·

Asan Medical Center, Seoul, Korea, Republic of

Randomized Phase II Trial of a PD-1 Inhibitor INCMGA00012 as Consolidation Therapy After Definitive Concurrent Chemoradiotherapy(RHAPSODY)

Phase 2
Not yet recruiting
Conditions
Esophageal Cancer
Interventions
Drug: INCMGA00012
First Posted Date
2020-07-31
Last Posted Date
2020-07-31
Lead Sponsor
Asan Medical Center
Target Recruit Count
110
Registration Number
NCT04494009

Diagnostic Validity of [18F]FSPG PET for the Assessment of Acute Rejection After Heart or Liver Transplantation

Phase 2
Completed
Conditions
Liver Transplantation
Graft Rejection
Heart Transplantation
Interventions
Drug: [18F]FSPG
First Posted Date
2020-07-27
Last Posted Date
2023-07-20
Lead Sponsor
Asan Medical Center
Target Recruit Count
7
Registration Number
NCT04488094
Locations
πŸ‡°πŸ‡·

Asan Medical Center, Seoul, Korea, Republic of

Change of Gut Microbiome and Symptom After H.Pylori Eradication Therapy in Patients With Functional Dyspepsia

First Posted Date
2020-06-26
Last Posted Date
2020-06-26
Lead Sponsor
Asan Medical Center
Target Recruit Count
60
Registration Number
NCT04449185

FFR and Inducible Myocardial Ischemia During Adenosine Stress Testing

Not Applicable
Conditions
Coronary Artery Stenosis
Interventions
Diagnostic Test: Fractional flow reserve with adenosine stress testing
First Posted Date
2020-05-26
Last Posted Date
2021-07-21
Lead Sponsor
Asan Medical Center
Target Recruit Count
150
Registration Number
NCT04401657
Locations
πŸ‡°πŸ‡·

Asan Medical Center, Seoul, Korea, Republic of

Sarcopenia and Outcomes of Neuroplasty in Lumbar Spinal Stenosis

Active, not recruiting
Conditions
Lumbar Spinal Stenosis
Neurogenic Claudication
Sarcopenia
Interventions
Procedure: Neuroplasty with Racz catheter
First Posted Date
2020-05-05
Last Posted Date
2022-12-27
Lead Sponsor
Asan Medical Center
Target Recruit Count
79
Registration Number
NCT04374669
Locations
πŸ‡°πŸ‡·

Asan medical center, Seoul, Korea, Republic of

Β© Copyright 2025. All Rights Reserved by MedPath